Dapagliflozin is not only clinically effective, but also cos

Dapagliflozin is not only clinically effective, but also cost effective in patients with chronic kidney disease

Dapagliflozin is not only clinically effective, but also cost effective in patients with chronic kidney disease

miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , United Kingdom , Washington , American , Phil Mcewan , Smith Kline , Vifor Fresenius , Johnjv Mcmurray , Ryan Miller , Davidc Wheeler , Klas Bergenheim , Hiddojl Heerspink , Oliver Darlington , Juan Jose Garcia Sanchez , Daichii Sankyo , Andrew Briggs , Glaxosmithkline , Amgen , Boehringer Ingelheim , Merck Co , Ma Health , Novartis , Sword Health , Pfizer , Astrazeneca , Health Economics , American Society Of Nephrology , Travere Pharmaceuticals , Oxford University Bayer , Phd Health Economics , Outcomes Research Ltd , Avalon Health Economics , Kidney Research United Kingdom , Novo Nordisk , Dapagliflozin And Prevention , Glaxo Smith Kline , Bristol Myers Squibb , Merck Sharp , Abbott Vascular , Chronic Kidney Disease , Health Economic Analysis , Assessing Affordability , Three European Countries , American Society ,